Title: Jill Adler-Moore: Innovator in Liposomal Vaccine Compositions
Introduction: Jill Adler-Moore is an inventor based in Rancho Dominguez, CA (US). He is known for his work in the field of liposomal formulations, particularly in developing vaccine compositions that stimulate immune responses in animals. Although he currently holds no granted patents, his contributions to the field are noteworthy.
Latest Patent Applications: Jill Adler-Moore's latest patent application is titled "Liposomal Formulations." This invention relates to liposomal vaccine compositions, methods for their manufacture, and methods for their use to stimulate an immune response in an animal. The compositions comprise liposomes formed from dimyristoylphosphatidylcholine (DMPC), either dimyristoylphosphatidylglycerol (DMPG) or dimyristoyltrimethylammonium propane (DMTAP), or both DMPC and DMTAP, along with at least one sterol and an antigenic polypeptide. The polypeptide includes a first sequence and a second sequence that is heterologous to the first, which comprises a transmembrane sequence from a membrane protein. This transmembrane sequence has a sufficient number of residues to cross a lipid bilayer, with at least nine contiguous residues predicted to form an alpha helix with a hydrophobicity score of about 0.7 or greater.
Conclusion: Jill Adler-Moore's innovative work in liposomal vaccine compositions highlights his commitment to advancing medical science, even in the absence of granted patents. His research has the potential to contribute significantly to immunology and vaccine development.